Nadim Khalil, MD

Biography

My primary research area is studying predisposing components and results linked with resistant gram-negative invasive infections. I’m investigating the risks that lead patients to have a higher chance of becoming infected due to a resistant pathogen.

I am very interested in pinpointing the risk factors that pose a greater likelihood of patients acquiring an infection from a resistant pathogen. Figuring out this information would be quite useful for providers treating patients at risk of aggressive infections by lowering the incidence of resistant pathogens.

I recognized my passion for infectious disease research during my medical school training. I worked with many patients with multi-drug resistant bacteria, including Vancomycin-resistant enterococci, multi-drug-resistant tuberculosis and Carbapenem-resistant Enterobacteriaceae. The exposure to these patients elevated my awareness of the rising rate of resistant bacteria around the world and the dangers they pose.

When I was in high school and college, I volunteered at a children’s cancer facility. Back then, I interacted with children who had a higher risk of infection. This experience led me to pursue a career in the medical field and, in particular, pediatrics healthcare. Ultimately, I settled on a specialty in pediatric infectious diseases.

During my career, I received the Helen’s Grant Fund (2017) from the Dartmouth-Hitchcock Medical Center. This award funded my research on the early onset neonatal sepsis systematic review.

My research has been published in the journal Diagnostic Microbiology and Infectious Disease. Lastly, I am fluent in English, French and Arabic. I’m learning Spanish and hope to become fluent soon.